Key Highlights
- Texas Instruments exceeded Q1 2026 expectations, reporting EPS of $1.68 versus the anticipated $1.36
- The company generated $4.83 billion in revenue, surpassing the projected $4.52 billion
- The Industrial division posted over 20% sequential growth; Data Center expanded by more than 25%
- Barclays moved TXN to Equalweight from Underweight, increasing its target from $175 to $250
- Analysts across Wall Street raised targets, with Rosenblatt reaching $330 and KeyBanc hitting $325
Texas Instruments delivered impressive first-quarter 2026 results that significantly exceeded Wall Street’s projections for both earnings and sales. The semiconductor giant reported earnings per share of $1.68, substantially higher than the consensus estimate of $1.36. Total revenue reached $4.83 billion compared to analyst forecasts of $4.52 billion.
Shares of the chipmaker surged approximately 16% following the announcement, climbing from roughly $233 to around $274 per share.
Texas Instruments Incorporated, TXN
The quarterly outperformance stemmed primarily from robust momentum across two critical business segments: Industrial and Data Center. The Industrial division recorded sequential growth exceeding 20% during the March quarter. Meanwhile, the Data Center segment expanded by more than 25% during the same timeframe.
Management’s outlook for the second quarter came in modestly above typical seasonal patterns, suggesting sustained demand momentum in both segments. However, UBS noted that Automotive sector demand continues to show volatility.
Wall Street Responds with Upgrades and Higher Targets
Barclays delivered the most significant rating change, elevating TXN from Underweight to Equalweight while dramatically raising its price objective from $175 to $250. The investment bank attributed the shift to strengthening fundamentals in the Industrial and Data Center markets.
Barclays projects Data Center revenue will expand by more than 90% throughout calendar year 2026. The firm also anticipates the Industrial segment will continue outperforming seasonal expectations through the June quarter.
The bank’s new financial model forecasts $10 per share in free cash flow for TXN during 2027. This projection exceeds the current Wall Street consensus of approximately $8.55.
UBS maintained its Buy recommendation while boosting its price target from $260 to $295. The firm noted that actual results matched heightened expectations, with forward guidance providing a modest upside surprise.
Cantor Fitzgerald increased its target from $250 to $280 while maintaining a Neutral stance. The firm expanded its valuation multiple to 28x from 25x, reflecting strengthening trends across the analog semiconductor sector.
Additional Analyst Commentary
KeyBanc established the highest price target on the Street, raising it to $325. BofA Securities upgraded the stock to Buy with a $320 objective, highlighting particular strength in aerospace and defense applications within the broader industrial category.
Rosenblatt pushed its target to $330. Baird increased its forecast to $300. Wolfe Research, which observed that Q1 revenue grew 9% sequentially, established a $315 target.
TXN currently commands a valuation of approximately 26 times free cash flow, well above its historical average in the mid-teens range. The stock’s price-to-earnings ratio stands at 43.15.
Barclays cautioned that the company still faces execution challenges regarding consensus estimates for the second half of the year. Cantor Fitzgerald also highlighted concerns about potential memory supply constraints and geopolitical risks as factors warranting selectivity within the semiconductor sector.
Shares were changing hands near $274, approaching the previous 52-week high of $238.80 established before the post-earnings surge.





